Cite
HARVARD Citation
Borgovan, T. et al. (2022). Innate immunity as a target for novel therapeutics in triple negative breast cancer. Expert opinion on investigational drugs. pp. 781-794. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Borgovan, T. et al. (2022). Innate immunity as a target for novel therapeutics in triple negative breast cancer. Expert opinion on investigational drugs. pp. 781-794. [Online].